Application of Transcatheter Arterial Chemoembolization (TACE) and Transarterial Chemoinfusion (TACI) in Sarcoma: A Case Series
DOI:
https://doi.org/10.35790/ecl.v13i3.62026Abstract
Abstract: Sarcomas are rare cancers with a dismal prognosis, and are still a great challenge for surgeons. Moreover, the development of treatment methods for sarcomas is currently heterogeneous. Transcatheter arterial chemoembolization (TACE) is a procedure that combines embolization and transarterial infusion chemotherapy (TACI). It targets the tumor bed with high doses of cytotoxic medicines while also inducing ischemia necrosis through arterial embolization. We presented a case series of patients treated with TACE and TACI for sarcoma. Two male patients with soft tissue sarcoma treated at Prof. Dr. R. D. Kandou Hospital, Manado. A 48-year-old male patient presented clinically with pain sensation and venectation in the right chest area, was diagnosed with thoracic soft tissue sarcoma. Another 72-year-old male complained of a painful lump and ulcers at the right flank area was diagnosed with right flank sarcoma. Both of these patients underwent the TACE and TACI procedure. Treatment outcome was assessed by examining the clinical morphology of the lesions and which showed a significant tumor reduction. According to the medical literature, TACE and TACI can benefit some patients, but TACE therapy's effectiveness in treating advanced STS, however, remains debatable. In conclusion, TACE and TACI were used as therapies in the two cases described, with a focus on the most recent developments and discussion of the need for more research to increase the efficacy of therapies.
Keywords: transcatheter arterial chemoembolization; transarterial infusion chemotherapy; sarcoma
References
Schneider P, Giglio V, Ghanem D, Wilson D, Turcotte R, Isler M, et al. Willingness of patients with sarcoma to participate in cancer surveillance research: a cross-sectional patient survey. BMJ Open 2021;11(2):e042742. Doi:10.1136/ bmjopen-2020-042742
Yamada R, Sato M, Kawabata M, Nakatsuka H, Nakamura K, Takashima S. Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology. 1983;148(2):397-401. Doi: 10.1148/radiology. 148.2.6306721
Li Z, Ji K, Bai L, Wang C, Hu Y, Shi Y, et al. A novel application of drug-eluting transarterial chemoembolization in treating non-liver cancers. Medicine 2020;99(31):e20878. Doi: 10.1097/MD.0000000000020878
Filho WJD, Uchiyama AAT, Marchon C, Lopes LMD, Baccarin AL de Castro, De Fina B, et al. A successful chemoembolization of a retroperitoneal soft tissue sarcoma: a case report. Case Rep Oncol 2021;14(3):1691-7. Doi: 10.1159/000520381
Jiang C, Wang J, Wang Y, Zhao J, Zhu Y, Ma X, et al. Treatment outcome following transarterial chemoembolization in advanced bone and soft tissue sarcomas. Cardiovasc Intervent Radiol. 2016;39(10):1420-8. Doi: 10.1007/s00270-016-1399-x
Vodanovich DA, Choong PFM. Soft-tissue sarcomas. Indian J Orthp. 2018;52(1):35-44. Doi: 10.4103/ortho.IJOrtho_220_17
Poedjomartono B, Bangun AA, Bachtiar R. Transcatheter arterial chemo infusion/TACI for breast cancer treatment: a case series. Indonesian Journal of Cancer. 2022;16(2):115-8. Available from: http://dx.doi.org/10.33371/ijoc.v16i2.874
Kotsifa E, Vergadis C, Vailas M, Machairas N, Kykalos S, Damaskos C, et al. Transarterial chemoembolization for hepatocellular carcinoma: Why, when, how? J Pers Med. 2022;12(3):436. Doi: 10.3390/jpm12030436
Mott BT, Iyer A, Smith E, Fargen K, Brown P, Wolfe SQW. Current indication for intraarterial chemotherapy in neurointerventional surgery. STROKE: Vascular and Interventional Neurology. 2022;3(2):e000425. Doi: 10.1161/SVIN.122.000425
Wang G, Zhang J, Liu H, Zheng Q, Sun P. Embolization alone is as effective as TACE for unresectable HCC: Systematic review and meta-analysis of randomized controlled trails. BMC Gastroenterol. 2024; 24(1):195. Doi: 10.1186/s12876-024-03282-z
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Adrian Tangkilisan, Wega Sukanto, Christa Tamburian, Gerald R. Lolongan
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
COPYRIGHT
Authors who publish with this journal agree to the following terms:
Authors hold their copyright and grant this journal the privilege of first publication, with the work simultaneously licensed under a Creative Commons Attribution License that permits others to impart the work with an acknowledgment of the work's origin and initial publication by this journal.
Authors can enter into separate or additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (for example, post it to an institutional repository or publish it in a book), with an acknowledgment of its underlying publication in this journal.
Authors are permitted and encouraged to post their work online (for example, in institutional repositories or on their website) as it can lead to productive exchanges, as well as earlier and greater citation of the published work (See The Effect of Open Access).
